Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

"Crediting conservation in Austin, the Save Our Springs Alliance said in an Aug. 16, 2011, entry in its online newsletter: ""Ten years ago the Austin Water Utility used a total of 240.3 million gallons. Every summer since then our peak day of water use has been lower."" After noting that this year’s peak water use in a day was 217 million gallons, the entry continues: ""So raise a tall glass of ice water in honor of our success: water conservation gains have outpaced population growth for a decade. Add a ‘Salud!’ to another 10 years of flat or declining water use — easily achieved with cost-effective conservation measures and an emerging ‘culture of conservation,’ one that recognizes that we can thrive and be happy without oversized, overwatered New England-style turf grass lawns."" We can’t check on the next decade, but we can check if peak water usage has been less every year than what it was in 2001. Indeed, the Austin Water Utility sent us figures indicating that on the peak days of water consumption from 2002 through August 2011, customers used less water than the 240.3 million gallons used on Aug. 13, 2001, though that was barely so in one year. The greatest peak use day since 2001 was Aug. 26, 2006, when usage was 240.17 million gallons — about 5/100ths of a percent shy of the amount gulped, flushed and otherwise used in 2001. The lowest peak-use amount in the 10 years after 2001 was 176.98 million gallons on Aug. 13, 2007. Put another way, the average peak water use in a day in the period was about 214 million gallons, 11 percent off the 2001 peak. The utility’s director, Greg Meszaros, told us in an interview that conservation helps explain the lower peak-use amounts, though he said consumption generally bounces around year to year partly due to variations in the weather — rainy summers reduce demand — and the economy. Per-capita water consumption has been relatively flat, Meszaros said, since the utility instituted a conservation program in 2007 that, among features, encourages customers to use low-water appliances and limit lawn watering. According to the utility, customers have used less water per person lately than individuals did in past years. Per-capita daily use has averaged 190 gallons or more four times since 1990, the last time being 2006. Average per-person consumption slid to 151 gallons in 2007, reached 170 gallons in 2008 and then dipped two straight years, reaching less than 140 gallons in 2010. Daryl Slusher, an assistant director for the utility, said the average will approach 160 gallons for the year that ends Sept. 30. Save Our Springs maintains the area’s conservation successes demonstrate that a water treatment plant slated for Northwest Austin won’t be needed for many years. Meszaros told us Austin needs the new plant because two current plants can’t be relied on indefinitely. Also, he said, the new project will include a vital water transmission main easing the delivery of water to the fast-growing northern third of the utility’s service area. ""We’re not doing (the new plant) just to meet a peak water demand,"" Meszaros said. In an interview, Bill Bunch, SOS’s executive director, expressed skepticism about strains in the existing water delivery system. He also said there’s not sufficient water demand to justify the new one and forwarded an April 2002 recommendation from city staff about preliminary engineering for the new plant. The document states the plant would be needed by 2009 to meet increasing water demands, predicting too that the utility’s peak one-day demand in summer 2009 would be 281 million gallons; the peak amount that year turned out to be 228 million gallons. Utility spokesman Kevin Buchman later told us by email that in 2002, the ""main reason for moving forward with the construction of a new plant was to meet the projected demands."" He said, though, the utility’s mid-decade focus on conservation allowed the city to postpone the plant’s completion by more than five years. ""Also,"" Buchman said, ""since 2002 we have had one of our (originally three) plants decommissioned and our other two water plants have been expanded as much as possible."" We won’t try to settle the water plant debate here. But the alliance’s statement about peak water use rates ."
Ten years ago the Austin Water Utility used a total of 240.3 million gallons. Every summer since then our peak day of water use has been lower.

The story provided several estimates for the cost of gastric banding; it also discussed insurance coverage, i.e. that the procedure was not always covered by insurance. While the story mentioned weight loss, health improvement, and longer life, it failed to provide quantitative estimates for these. The story provided quantitative information on the disease reduction obtained with the use of this device in individuals with type II diabetes. Although the story did mention that weight loss is slower with gastric banding than with gastric bypass, it failed to provide quantitative information about the amount or rate of weight loss attained with banding. The story should also have mentioned that long-term followup finds for those whose diabetes resolves following gastric banding, about half re-develop diabetes at 10 years. The story mentioned weight regain as well as some of the side effects that occur with the use of this device. For a more complete discussion, it should have included information about how frequently these occur. When discussing the effect of gastric banding on type II diabetes, the story mentioned the research about the use of this device for this population. It mentioned the evidence about safety and effectiveness and where it had been published. As for the impact of the banding procedure on weight, the story neglected to include information on the average weight loss seen but did include several patient anecdotes. However the story was more focused on the marketing strategies for this device rather than the health claims per se. The story did not engage in disease mongering. The story included primary quotes from clinicians, industry spokespersons, and individuals who had undergone gastric banding. The story included a pretty comprehensive comparison between gastric banding and gastric bypass, another type of weight loss surgery. It only mentioned diet and exercise in passing and failed to mention medication that can be used for weight loss. The story provided a very complete discussion about the various venues at which gastric banding was available. The story provided a pretty complete history of the use of gastric banding. Does not rely on a press release
Industry Giants Push Obesity Surgery

The FDA said it received 85 reports from patients who switched from Wellbutrin XL to Teva Pharmaceutical Industries Ltd and Impax Laboratories Inc’s cheaper generic, including 78 who said they slipped back into depression. Other patients reported new or worsening side effects, including headaches, fatigue, anxiety and digestion issues. “The question is whether the reported lack of efficacy and/or new onset side effects in these patients who switched suggest a problem with the generic product ... or have some other explanation,” the FDA said in a statement on its website. Agency scientists reviewed 300-milligram versions of the two drugs, which both use once-a-day formulations of the chemical bupropion, and found the data did not show that the problems stemmed from any differences between the two drugs. One factor that could account for the reported problems is the natural recurrence of depression, which can happen despite treatment, the FDA said. Half of the patients who went back on the name-brand drug said they improved, the agency said, adding that it would continue to monitor the issue. FDA officials received the reports during the first half of 2007. Teva and Impax’s version of Wellbutrin was approved in 2006. Watson Pharmaceuticals Inc also makes a 300-mg XL version of bupropion, though it was not part of the FDA’s review. GlaxoSmithKline makes other versions of Wellbutrin that face generic competition. Total sales of Wellbutrin slipped 37 percent last year in the face of generic competition, the company has reported. The drugmaker could not comment on the FDA’s conclusion because it did not have access to the data used but is pleased the agency would continue its monitoring, GlaxoSmithKline spokeswoman Mary Anne Rhyne said. Teva spokeswoman Denise Bradley said the company would issue a statement later. Shares of GlaxoSmithKline rose 39 cents to $42.47 on the New York Stock Exchange. Teva rose 65 cents, or 1.4 percent, to $46.67 on Nasdaq.

FDA says generic Wellbutrin OK despite reports.